Article

Atomistic Profiling of KRAS Interactions with Monobodies and Affimer Proteins Through Ensemble-Based Mutational Scanning Unveils Conserved Residue Networks Linking Cryptic Pockets and Regulating Mechanisms of Binding, Specificity and Allostery

2025-03-14

Abstract excerpt

KRAS, a historically “undruggable” oncogenic driver, has eluded targeted therapies due to its lack of accessible binding pockets in its active state. This study investigates the conformational dynamics, binding mechanisms, and allosteric communication networks of KRAS in complexes with monobodies (12D1, 12D5) and affimer proteins (K6, K3, K69) to characterize the binding and allosteric mechanisms and hotspots of K...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 86ad6834-db98-5afb-96e3-5b81b820cbab
DOI: 10.1101/2025.03.11.642708

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Atomistic Profiling of KRAS Interactions with Monobodies and Affimer Proteins Through Ensemble-Based Mutational Scanning Unveils Conserved Residue Networks Linking Cryptic Pockets and Regulating Mechanisms of Binding, Specificity and AllosteryDOI 10.1101/2025.03.11.642708Read

The energetic and allosteric landscape for KRAS inhibition.Semantic proximity Read

The energetic and allosteric landscape for KRAS inhibitionSemantic proximity Read

Structural and Energetic Determinants of Monobody Recognition of Oncogenic KRAS VariantsSemantic proximity Read

Analysis of KRAS-Ligand Interaction Modes and Flexibilities Reveals the Binding Characteristics.Semantic proximity Read

Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.Semantic proximity Read

Discovery of allosteric non-covalent KRAS inhibitors that bind with sub-micromolar affinity and disrupt effector bindingSemantic proximity Read

Inside the cracked kernel: establishing the molecular basis of AMG510 and MRTX849 in destabilising KRASG12C mutant switch I and II in cancer treatment.Semantic proximity Read

RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric siteSemantic proximity Read

Beyond Structural Bioinformatics for Genomics with Dynamics Characterization of an Expanded KRAS Mutational LandscapeSemantic proximity Read

Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy.Semantic proximity Read

Beyond KRAS(G12C): Biochemical and Computational Characterization of Sotorasib and Adagrasib Binding Specificity and the Critical Role of H95 and Y96.Semantic proximity Read

Allosteric Binding-Mediated Suppression on Activity of G12D KRAS Recognized via Markov State Model and Communication Pathway.Semantic proximity Read